What the studies show
Aged rats given pinealon before hypoxia showed behavioural and caspase-3 changes in several small studies from the same institute.
Animal studies, cell studies, or anecdotes only. This is where almost every viral peptide sits. Promising and proven are different words for a reason.
- 1
In context
Pinealon is the tripeptide Glu-Asp-Arg, a synthetic 'bioregulator' from the St Petersburg group behind epitalon, sold for brain ageing and stress. Its indexed evidence is cell culture — it reduced free radicals and cell death in vitro — and rat experiments in hypoxia. The human reports are Russian-language, without controls and without indexed abstracts. No randomised trial exists. It is not approved anywhere this site covers.
Pinealon is not approved. Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is Pinealon proven to help with hypoxia tolerance?
What studies are behind the grade?
Is Pinealon approved for this?
Other outcomes for Pinealon
- DCognition or brain ageing (human)0 controlled; Russian reports without abstracts
- DCell viability under oxidative stress (in vitro)Cell culture only
Written and maintained by LYO Research — how pages are written and checked. Reviewed 23 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →